LB-100, a novel Protein Phosphatase 2A (PP2A) Inhibitor, Sensitizes Malignant Meningioma Cells to the Therapeutic Effects of Radiation

Atypical and anaplastic meningiomas (AAM) represent 20% of all meningiomas. They are associated with poor outcomes due to their tendency to recur. While surgery and radiation (RT) are first line therapy, no effective systemic medical treatment has been identified. Protein phosphatase 2A (PP2A) is a...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Cancer Lett
Główni autorzy: Ho, Winson SC., Sizdahkhani, Saman, Hao, Shuyu, Song, Hua, Seldomridge, Ashlee, Tandle, Anita, Maric, Dragan, Kramp, Tamalee, Lu, Rongze, Heiss, John D., Camphausen, Kevin, Gilbert, Mark R., Zhuang, Zhengping, Park, Deric M.
Format: Artigo
Język:Inglês
Wydane: 2017
Hasła przedmiotowe:
Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5748254/
https://ncbi.nlm.nih.gov/pubmed/29199006
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2017.11.035
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy